Healthcare

By

Jim Cramer

 | Feb 28, 2017 | 11:30 AM EST
Let's recognize that some moves are simply related to bonds, which are in the grips of a bizarre developed-world shortage.
By

Bruce Kamich

 | Feb 27, 2017 | 11:23 AM EST
Check out GSK's well developed base pattern.
By

Bruce Kamich

 | Feb 27, 2017 | 10:14 AM EST
Novartis has seen some very aggressive buying the past five months -- time to join in.
By

Bruce Kamich

 | Feb 27, 2017 | 9:22 AM EST
SNY has become much stronger since late October; buy here and above $44.
By

James "Rev Shark" DePorre

 | Feb 24, 2017 | 11:44 AM EST
If you play strong defense, be prepared to change course very quickly.
By

Bret Jensen

 | Feb 24, 2017 | 11:30 AM EST
Readers want to know what to do with the two biotech names, which are headed in opposite directions.
RMPIA
By

Jim Cramer

 | Feb 24, 2017 | 6:08 AM EST
You have to keep up with the sector rotations.
By

James "Rev Shark" DePorre

 | Feb 22, 2017 | 1:52 PM EST
But it is all about timing, and so far there is no indication that this extended market is about to turn.
RMPIA
By

Jim Cramer

 | Feb 22, 2017 | 11:45 AM EST
Icahn may have a tough time finding interest in this behemoth.
By

James "Rev Shark" DePorre

 | Feb 22, 2017 | 10:47 AM EST
It will be interesting to see today if afternoon strength occurs once again.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.